1.Epidemiology of Salmonella enterica Serotype Typhi Infections in Korea for Recent 9 Years: Trends of Antimicrobial Resistance.
Sunmi YOO ; Hyunjoo PAI ; Jeong hum BYEON ; Youn Ho KANG ; Shukho KIM ; Bok Kwon LEE
Journal of Korean Medical Science 2004;19(1):15-20
The aim of this study is to characterize the epidemiological features of typhoid fever, categorized as class 1 notifiable disease in Korea and to analyze the recent change of antimicrobial resistance of Salmonella enterica serotype Typhi isolated nationwide. We retrospectively analyzed the 1,692 culture-proven cases from 1992 to 2000, using the data of the Korean National Institute of Health. The overall incidence of culture-proven typhoid fever was 0.41 per 100,000 population. It occurred all over the country, but the southeastern part of Korean peninsula had the higher incidence rate than other areas. There were several outbreaks suspected, of which two outbreaks were confirmed. The resistance rate against chloramphenicol showed mild increase, but the ampicillin, trimethoprim/sulfamethoxazole, kanamycin, or nalidixic acid resistance remained at the similar levels for the past 9 yr. There were 21 (1.3%) multidrug-resistant (MDR) strains isolated since 1992, and the number of those has increased. Two strains resistant to ciprofloxacin were first identified in Korea.
Ampicillin/pharmacology
;
Anti-Bacterial Agents/pharmacology
;
Chloramphenicol/pharmacology
;
*Drug Resistance, Microbial
;
Drug Resistance, Multiple
;
Human
;
Kanamycin/pharmacology
;
Korea
;
Nalidixic Acid/pharmacology
;
Retrospective Studies
;
Salmonella Infections/*epidemiology
;
Salmonella enterica/*metabolism
;
Seasons
;
Serotyping
;
Support, Non-U.S. Gov't
;
Time Factors
;
Trimethoprim/pharmacology
2.Pathogen translocation and histopathological lesions in an experimental model of Salmonella Dublin infection in calves receiving lactic acid bacteria and lactose supplements.
Laureano S FRIZZO ; Maria V ZBRUN ; Lorena P SOTO ; Ezequiel BERTOZZI ; Gabriel J SEQUEIRA ; Luis E MARTI ; Marcelo L SIGNORINI ; Roberto Rodriguez ARMESTO ; Marcelo R ROSMINI
Journal of Veterinary Science 2012;13(3):261-270
The purpose of this study was to evaluate the capacity of a lactic acid bacteria (LAB) inoculum to protect calves with or without lactose supplements against Salmonella Dublin infection by evaluating histopathological lesions and pathogen translocation. Fifteen calves were divided into three groups [control group (C-G), a group inoculated with LAB (LAB-G), and a group inoculated with LAB and given lactose supplements (L-LAB-G)] with five, six, and four animals, respectively. The inoculum, composed of Lactobacillus (L.) casei DSPV 318T, L. salivarius DSPV 315T, and Pediococcus acidilactici DSPV 006T, was administered with milk replacer. The LAB-G and L-LAB-G received a daily dose of 109 CFU/kg body weight of each strain throughout the experiment. Lactose was provided to the L-LAB-G in doses of 100 g/day. Salmonella Dublin (2 x 1010 CFU) was orally administered to all animals on day 11 of the experiment. The microscopic lesion index values in target organs were 83%, 70%, and 64.3% (p < 0.05) for the C-G, LAB-G, and L-LAB-G, respectively. Administration of the probiotic inoculum was not fully effective against infection caused by Salmonella. Although probiotic treatment was unable to delay the arrival of pathogen to target organs, it was evident that the inoculum altered the response of animals against pathogen infection.
Administration, Oral
;
Animals
;
Animals, Newborn
;
Cattle
;
Cattle Diseases/*drug therapy/microbiology/pathology
;
Dietary Supplements/*analysis
;
Feces/microbiology
;
Lactobacillus/metabolism
;
Lactose/*metabolism
;
Male
;
Pediococcus/metabolism
;
Probiotics/*therapeutic use
;
Salmonella Infections, Animal/*drug therapy/microbiology/pathology
;
Salmonella enterica/*drug effects/growth & development
;
Tissue Distribution